Myeong Soo Lee is Principal Researcher in the Division of Standard Research at the Korea Institute of Oriental Medicine in Daejeon, South Korea and an Honorary University Fellow at the Complementary Medicine group at the Peninsula Medical School in Exeter, UK.
The Integrative Canadian Oncology (ICON) Research Initiative aims to provide a vision and a voice for integrative oncology research in Canada.
Given the increased focus on the integration of evidence-based CAM and conventional cancer treatments, the former CAM and cancer Canadian research team decided to shift its research endeavors to integrative oncology rather than CAM alone.
ICON's objectives are to:
The Anticancer Fund is a foundation of public utility providing research-based information on cancer therapies and selectively funding the development of promising therapies.
The Anticancer Fund is dedicated to expanding the range of treatment options available to patients, regardless of their commercial value.
The University Hospital Zurich is one of the largest and most important teaching hospitals in Europe. With its 43 departments and institutes, the hospital is renowned for its achievements in health care, research and teaching. The Institute for Complementary and Integrative Medicine has an outpatient clinic and offers various types of consultations for patients with cancer with a focus on acupuncture, phytotherapy and mind/body medicine.
The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate translational and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patient quality of life. Extensive and comprehensive research in this wide field is often beyond the means of individual European hospitals, and can best be accomplished through the multidisciplinary multinational efforts of basic scientists and clinicians.
The Department of Oncology and Hematology at the Klinikum Nuernberg, Germany, has since 1989 been running a study group entitled „AG Biologische Krebstherapie“ in order to investigate and assess the efficacy and safety of complementary and alternative medicine (CAM) in the care of cancer patients.
Our unit is specifically devoted to clinical research in this area. It was established in 1993 following a substantial endowment from The Maurice Laing Foundation. Today it is an internationally recognised centre of excellence in the area of complementary medicine research.
Do mistletoe injections, nutritional supplements or shark cartilage really fight cancer? What are the risks and side-effects of complementary and alternative therapy methods? The Swiss “Study Group for Complementary and Alternative Methods in Cancer” is committed to studying these and other related questions.
Norway's National Research Center in Complementary and Alternative Medicine
We work to give you facts about complementary and alternative medicine, so that you can make safer choices for your health.
Other websites from NAFKAM: